Health insurance; coverage for cancer follow-up testing; report. Requires health insurers and other carriers to provide coverage for cancer follow-up testing, as defined in the bill, and prohibits the imposition of deductibles, coinsurance, or any other cost-sharing requirements specifically on cancer follow-up testing. The bill directs the Bureau of Insurance to annually report to the General Assembly on (i) the number of individuals benefiting from the removal of copayments for cancer follow-up testing, (ii) the financial impact on health insurance premiums as a result of the provisions of the bill, and (iii) recommendations for further policy adjustments.
No hearings or votes scheduled.